Evofem reports Q3 2026 net income of $0.9 million

Evofem reported third-quarter 2026 net sales of $4.6 million and net income attributable to common stockholders of $0.9 million. Operating income was $0.7 million, compared with $1.0 million in the year-ago quarter. The company cited lower PHEXX ex-factory sales, partly offset by higher SOLOSEC uni…